ClinicalTrials.gg
Sign In

Kidney Diseases clinical trials

The registry lists 969 studies for Kidney Diseases across more than 10 countries. 183 are recruiting or about to start. 319 of them are mainly about Kidney Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 43 narrower conditions too, such as Renal Insufficiency, Chronic: 13,681 studies, 2,837 open.

ClinicalTrials.gov finds 16,447 studies for Kidney Diseases. How that becomes 968 here

This page counts the studies the registry files under Kidney Diseases, and those it files under no condition that list Kidney Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 16,447Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −12,373Filed under a narrower condition, counted on its own pageRenal Insufficiency, Chronic 2,895 · Carcinoma, Renal Cell 1,937 · Kidney Failure, Chronic 1,602 · Acute Kidney Injury 1,473 · Renal Insufficiency 972 · Kidney Calculi 488 · 35 more
  3. −237List Kidney Diseases as a condition, but the registry did not file them under itMost often written as “Chronic Kidney Disease Requiring Chronic Dialysis” (32), “Anemia of Chronic Kidney Disease” (24), and “Chronic Kidney Disease 5D” (12). The registry filed 146 of them under no condition at all, and the others under other conditions only, most often Anemia (16) and Hyperparathyroidism, Secondary (7).
  4. −2,869Match it another way313 name it in the title, 12 in a keyword, and 2,544 by a synonym or other text the search reads.
  5. 968The count on this page

Get an email when these change. Save the Kidney Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
540
Recruiting
128
Status unknown
92
Terminated
65
Active, not recruiting
57
Not yet recruiting
48

Phase

Phase 2
146
Phase 3
123
Phase 1
102
Phase 4
93
Early Phase 1
7

Where

United States
415
Canada
83
France
80
United Kingdom
62
China
59
Germany
59

Who runs them

Amgen (24) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (17) · Brigham and Women's Hospital (13) · University of Colorado, Denver (13) · National Institute of Allergy and Infectious Diseases (NIAID) (11) · Novartis Pharmaceuticals (10) · AstraZeneca (10) · Duke University (9)

What is being tested here

Drugs under test in Kidney Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Finerenone234
JADE101212
Darbepoetin alfa1815
Dapagliflozin137
Atrasentan135
Sparsentan103
Empagliflozin113
Folic Acid113
Valsartan123
Zigakibart122

Drug classes tested here SGLT2 inhibitors 4 open · Angiotensin receptor blockers (ARBs) 2 open · Endothelin receptor antagonists 2 open · Mineralocorticoid receptor antagonists (MRAs) 2 open · GLP-1 receptor agonists 2 open

Coming up

23phase 3 studies under way
69studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 128 Kidney Diseases studies recruiting now, 75 (59%) set no upper age limit and 33 (26%) stop at 75 or younger. 25 (20%) take children under 18. 6 (5%) are for women only and 3 (2%) for men only; 22 (17%) take healthy volunteers.

Recruiting studies that take each age, of 128
AgeWomenMen
1021 (16%)19 (15%)
18104 (81%)101 (79%)
30109 (85%)105 (82%)
40110 (86%)107 (84%)
50111 (87%)109 (85%)
65111 (87%)108 (84%)
7598 (77%)95 (74%)
8584 (66%)82 (64%)

Across all 969 studies, recruiting or not: 28% stop at 75 or younger and 15% at 65; 18% take children; 2% are for women only and 2% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Kidney Diseases studies take

Of 45 phase 3 interventional studies under Kidney Diseases, half reached primary completion within 55 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 113 mo8–29 · 31 studies12 mo6–21 · 27 studies—
Phase 226 mo19–43 · 41 studies——
Phase 355 mo26–69 · 45 studies——
Phase 433 mo12–68 · 22 studies——
Interventional, no phase34 mo13–49 · 148 studies—36 mo14–52 · 128 studies
Observational59 mo28–118 · 116 studies—68 mo33–… · 99 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Results posted1

Stopped1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 969. Browse all 969 → or search them.